Poland - Warsaw: Pharmaceutical products

Release

ID
ocds-pyfy63:2017-207295:2017-207295
Date
2017-06-01
Language
PL
Tags
tender

Release in JSON

Process

ID (OCID)
ocds-pyfy63:2017-207295
Releases
2017-06-01 (ocds-pyfy63:2017-207295:2017-207295)
2017-12-16 (ocds-pyfy63:2017-207295:2017-502808)

Releases in JSON

Tender

Title
Poland - Warsaw: Pharmaceutical products
Award criteria
priceOnly
Award criteria details
Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price

Award criteria for item 50:
- Price

Award criteria for item 51:
- Price

Award criteria for item 52:
- Price

Award criteria for item 53:
- Price

Award criteria for item 54:
- Price

Award criteria for item 55:
- Price

Award criteria for item 56:
- Price

Award criteria for item 57:
- Price

Award criteria for item 58:
- Price

Award criteria for item 59:
- Price

Award criteria for item 60:
- Price

Award criteria for item 61:
- Price

Award criteria for item 62:
- Price

Award criteria for item 63:
- Price

Award criteria for item 64:
- Price

Award criteria for item 65:
- Price

Award criteria for item 66:
- Price

Award criteria for item 67:
- Price

Award criteria for item 68:
- Price

Award criteria for item 69:
- Price

Award criteria for item 70:
- Price

Award criteria for item 71:
- Price

Award criteria for item 72:
- Price

Award criteria for item 73:
- Price

Award criteria for item 74:
- Price

Award criteria for item 75:
- Price

Award criteria for item 76:
- Price

Award criteria for item 77:
- Price

Award criteria for item 78:
- Price
Award period
2017-07-11 - ?
Eligibility criteria
Suitability:

W przypadku składania oferty na produkty lecznicze o udzielenie zamówienia mogą ubiegać się Wykonawcy, którzy spełniają warunki określone w art. 22 ust. 1b ustawy, dotyczące kompetencji lub uprawnień do prowadzenia określonej działalności zawodowej, o ile wynika to z odrębnych przepisów. Wykonawca spełni warunek jeżeli wykaże, że posiada uprawnienia do prowadzenia obrotu produktami leczniczymi zgodnie z ustawą z dnia 6.9.2001 r. Prawo farmaceutyczne (Dz. U. 2016r. poz. 2142 ze zm.).), czyli jeśli posiada zezwolenie lub dokument potwierdzający, że Wykonawca jest wpisany do jednego z rejestrów zawodowych lub handlowych, prowadzonych w państwie członkowskim Unii Europejskiej, w którym Wykonawca ma siedzibę lub miejsce zamieszkania;
Main procurement category
goods
Procurement method
open
Procurement method details
Open procedure
Tender period
2017-06-01 - 2017-07-11
Value
58 863 704.10 PLN
Minimum value
58 863 704.10 PLN

Tender item

ID
ocds-pyfy63:2017-207295:obj:1
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Doxorubicin – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:2
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Cladribine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:3
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Bleomycin – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:4
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Doxorubicin- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:5
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Irinotecan – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:6
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Carboplatin – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:7
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Cisplatinum – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:8
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Cytarabinum – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:9
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Cytarabine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:10
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Cytarabine DepoCyte- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:11
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Cyclophosphamid – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:12
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Etoposide – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:13
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Epirubicin – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:14
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Fludarabine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:15
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Fluorouracil. – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:16
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Gemcitabine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:17
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Trastuzumab- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:18
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Trastuzumab- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:19
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Ifosfamid – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:20
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Topotecan – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:21
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Calcii folinas – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:22
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Levofolic acid – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:23
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Rituximab – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:24
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Methotrexat – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:25
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Mitomycin C- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:26
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Mitoxantrone – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:27
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Vinorelbine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:28
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Asparaginase – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:29
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Pegaspargase – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:30
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Oxaliplatine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:31
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Paclitaxel – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:32
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Docetaxel – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:33
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Mesnum – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:34
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Panitumumab- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:35
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Bortezomid – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:36
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Azacitidine- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:37
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Vinblastin- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:38
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Vincristine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:39
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Idarubicine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:40
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Doxorubicin- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:41
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Bendamustinum – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:42
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Brentuksymab vedotin – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:43
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Obinutuzumab – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:44
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Temsyrolimus – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:45
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Paklitaksel – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:46
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Nelarabina- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:47
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Nivolumab- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:48
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Trójtlenek arsenu- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:49
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Pertuzumab- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:50
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Bendamustinum- 2 pozycje asortymentowe.

Tender item

ID
ocds-pyfy63:2017-207295:obj:51
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Pemetrexed – 2 pozycje asortymentowe.

Tender item

ID
ocds-pyfy63:2017-207295:obj:52
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Dacarbazine – 3 pozycje asortymentowe.

Tender item

ID
ocds-pyfy63:2017-207295:obj:53
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Rituximab – 2 pozycje asortymentowe.

Tender item

ID
ocds-pyfy63:2017-207295:obj:54
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Bevacizumab – 2 pozycje asortymentowe.

Tender item

ID
ocds-pyfy63:2017-207295:obj:55
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Carmustine liofilizat + rozpuszczalnik – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:56
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Dactinomycin – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:57
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Daunorubicin- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:58
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Melphalan – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:59
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Busulfan – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:60
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Treosulfan – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:61
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Acidum Zolendronicum- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:62
Classification
CPV / 33600000
Additional classifications
CPV / 33616000
Description
Ascorbic Acid- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:63
Classification
CPV / 33600000
Additional classifications
CPV / 33621100
Description
Cytrynian sodu – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:64
Classification
CPV / 33600000
Additional classifications
CPV / 33661000
Description
Deksmedeteomidine – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:65
Classification
CPV / 33600000
Additional classifications
CPV / 33661000
Description
Ephedrine Hydrochloride – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:66
Classification
CPV / 33600000
Additional classifications
CPV / 33661100
Description
Fentanyl- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:67
Classification
CPV / 33600000
Additional classifications
CPV / 33661100
Description
Fentanyl – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:68
Classification
CPV / 33600000
Additional classifications
CPV / 33622300
Description
Furosemide – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:69
Classification
CPV / 33600000
Additional classifications
CPV / 33696000
Description
Gadobutrol – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:70
Classification
CPV / 33600000
Additional classifications
CPV / 33632100
Description
Lidocaine Hydrochloride, methylprednisolone acetate – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:71
Classification
CPV / 33600000
Additional classifications
CPV / 33651100
Description
Meropenemum- 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:72
Classification
CPV / 33600000
Additional classifications
CPV / 33652100
Description
Netupitantum, Palonosetronum – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:73
Classification
CPV / 33600000
Additional classifications
CPV / 33661200
Description
Paracetamol – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:74
Classification
CPV / 33600000
Additional classifications
CPV / 33661100
Description
Propofol – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:75
Classification
CPV / 33600000
Additional classifications
CPV / 33660000
Description
Thiethylperazinum – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:76
Classification
CPV / 33600000
Additional classifications
CPV / 33696400
Description
Mikrosfery żywicze – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:77
Classification
CPV / 33600000
Additional classifications
CPV / 33692800
Description
Płyn stosowany do leczenia niewydolności nerek – 1 pozycja asortymentowa.

Tender item

ID
ocds-pyfy63:2017-207295:obj:78
Classification
CPV / 33600000
Additional classifications
CPV / 33181510
Description
Płyn do antykoagulacji cytrynianowej, płyn do dializy, roztwór do hemodializy/hemofiltracji, płyn substytucyjny, dializacyjny, worek spustowy – 5 pozycji asortymentowych.

Parties

Roles
buyer
Organization name
Wojskowy Instytut Medyczny
Street address
ul. Szaserów 128
Locality
Warszawa
Postal code
04-141
Country
PL
Contact name
Katarzyna Czarnocka
E-mail
kczarnocka@wim.mil.pl
Phone
+48 261816226
Fax
+48 225150600
Website
Link

Organization data Organization in JSON